Protein-based antigen presentation platforms for nanoparticle vaccines

Abstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases suc...

Full description

Bibliographic Details
Main Authors: Brian Nguyen, Niraj H. Tolia
Format: Article
Language:English
Published: Nature Publishing Group 2021-05-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-021-00330-7
id doaj-48d7babf85fb43848b0cf587c51a6749
record_format Article
spelling doaj-48d7babf85fb43848b0cf587c51a67492021-05-16T11:23:20ZengNature Publishing Groupnpj Vaccines2059-01052021-05-016111110.1038/s41541-021-00330-7Protein-based antigen presentation platforms for nanoparticle vaccinesBrian Nguyen0Niraj H. Tolia1Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of HealthLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of HealthAbstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases such as COVID-19, malaria, and AIDS there is a clear urgency for more effective next-generation vaccines. One approach to improve the immunogenicity of vaccines is the use of nanoparticle platforms that present a repetitive array of antigen on its surface. This technology has been shown to improve antigen presenting cell uptake, lymph node trafficking, and B-cell activation through increased avidity and particle size. With a focus on design, we summarize natural platforms, methods of antigen attachment, and advancements in generating self-assembly that have led to new engineered platforms. We further examine critical parameters that will direct the usage and development of more effective platforms.https://doi.org/10.1038/s41541-021-00330-7
collection DOAJ
language English
format Article
sources DOAJ
author Brian Nguyen
Niraj H. Tolia
spellingShingle Brian Nguyen
Niraj H. Tolia
Protein-based antigen presentation platforms for nanoparticle vaccines
npj Vaccines
author_facet Brian Nguyen
Niraj H. Tolia
author_sort Brian Nguyen
title Protein-based antigen presentation platforms for nanoparticle vaccines
title_short Protein-based antigen presentation platforms for nanoparticle vaccines
title_full Protein-based antigen presentation platforms for nanoparticle vaccines
title_fullStr Protein-based antigen presentation platforms for nanoparticle vaccines
title_full_unstemmed Protein-based antigen presentation platforms for nanoparticle vaccines
title_sort protein-based antigen presentation platforms for nanoparticle vaccines
publisher Nature Publishing Group
series npj Vaccines
issn 2059-0105
publishDate 2021-05-01
description Abstract Modern vaccine design has sought a minimalization approach, moving to the isolation of antigens from pathogens that invoke a strong neutralizing immune response. This approach has created safer vaccines but may limit vaccine efficacy due to poor immunogenicity. To combat global diseases such as COVID-19, malaria, and AIDS there is a clear urgency for more effective next-generation vaccines. One approach to improve the immunogenicity of vaccines is the use of nanoparticle platforms that present a repetitive array of antigen on its surface. This technology has been shown to improve antigen presenting cell uptake, lymph node trafficking, and B-cell activation through increased avidity and particle size. With a focus on design, we summarize natural platforms, methods of antigen attachment, and advancements in generating self-assembly that have led to new engineered platforms. We further examine critical parameters that will direct the usage and development of more effective platforms.
url https://doi.org/10.1038/s41541-021-00330-7
work_keys_str_mv AT briannguyen proteinbasedantigenpresentationplatformsfornanoparticlevaccines
AT nirajhtolia proteinbasedantigenpresentationplatformsfornanoparticlevaccines
_version_ 1721439468424003584